Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Farmak is a prominent Ukrainian pharmaceutical company, holding a leading position in its domestic market and serving as the country's largest exporter of medicinal products. Founded in 1925, Farmak specializes in the research, development, manufacturing, and marketing of a wide range of high-quality generic and some original medicines. The company's portfolio covers key therapeutic areas including endocrinology, gastroenterology, cardiology, neurology, and anti-cold treatments, among others. Farmak is committed to innovation, adheres to international Good Manufacturing Practice (GMP) standards, and actively expands its presence in global markets.
Serves as the central hub for corporate management, strategic planning, research and development, primary manufacturing operations, and international market coordination.
Features state-of-the-art manufacturing lines compliant with EU GMP standards, advanced R&D laboratories, and quality control centers.
A dynamic and innovative environment focused on scientific excellence, quality assurance, continuous improvement, and employee development. Emphasis on collaboration and contribution to public health.
The headquarters is pivotal to Farmak's operations, being the heart of its production and innovation, and a key contributor to Ukraine's pharmaceutical independence and export capabilities.
Farmak has a significant global footprint, exporting its pharmaceutical products to over 50 countries worldwide. This includes markets in the European Union, Central and South America, CIS countries, the Middle East, and Asia. Globally, Farmak supports functions such as international sales and marketing, regulatory affairs, business development, and logistics through its network of representative offices and partnerships.
74, Kyrylivska St.
Kyiv
Kyiv City
Ukraine
Address: Farmak International Sp. z o.o., Warsaw (Specific street address may vary)
Strengthening Farmak's footprint in the European Union, facilitating partnerships, and navigating the EU regulatory landscape.
Address: API Manufacturing Plant, Shostka (Specific site details)
Ensuring a stable supply of high-quality APIs for Farmak's finished dosage forms and reducing reliance on external suppliers.
Address: Representative Office in Tashkent (Specific street address may vary)
Developing and expanding Farmak's market share in the strategically important Central Asian region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Farmak' leadership includes:
Farmak has been backed by several prominent investors over the years, including:
No major C-suite (CEO, CFO, COO) leadership changes have been publicly reported for Farmak in the last 12 months, indicating stability in its top executive team. Ongoing strategic roles and responsibilities continue to be managed by the established leadership.
Discover the tools Farmak uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Farmak likely utilizes several common corporate email formats. Based on typical patterns and public contact information, common structures could include the first initial followed by the last name, or the full first name separated from the last name by a dot.
[first_initial][last]@farmak.ua
Format
vkostiuk@farmak.ua
Example
70%
Success rate
Interfax-Ukraine • February 14, 2024
Farmak, Ukraine's leading pharmaceutical manufacturer, announced it invested UAH 1.5 billion (approx. $40 million) in its development throughout 2023. These significant investments were directed towards research and development of new medicines, modernization of existing production facilities, and strategic expansion into new international markets....more
Farmak Official Website • November 20, 2023
Farmak has officially opened a new representative office, Farmak International Sp. z o.o., in Warsaw, Poland. This move is a key part of its European expansion strategy, aimed at strengthening the company's presence and improving the accessibility of its pharmaceutical products within the EU market....more
GMK Center / Industry Media • February 27, 2024
Farmak is making significant progress in the construction of its new state-of-the-art manufacturing facility near Barcelona, Spain. This project, with an investment exceeding €20 million, is set to bolster Farmak's production capabilities and further facilitate its access to European and global markets upon completion....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Farmak, are just a search away.